Dermapharm
Offers dermatological, skin care, and allergy medicines.
Market cap
$2.0b
Enterprise value
$3.0b
Share price
€34.60 DMP.F
| Date | Investors | Amount | Round |
|---|---|---|---|
* | N/A | €375m Valuation: €1.5b | IPO |
| Total Funding | 000k | ||
No items found
No investors found
| EUR | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 19 % | 9 % | 11 % | 4 % | - | 4 % | 4 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 37 % | 32 % | 23 % | 27 % | 28 % | 28 % | 28 % |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 22 % | 13 % | 5 % | 10 % | 11 % | 11 % | 12 % |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 2 % | 1 % | 1 % | 1 % | - | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Dermapharm
Edit
ACQUISITION by Dermapharm Jan 2023
ACQUISITION by Dermapharm Dec 2021
